Immune Health Supplements Market Size Worth $132.0 Billion By 2028: Grand View Research, Inc.

SAN FRANCISCO, Oct. 7, 2021 /PRNewswire/ -- The global immune health supplements market size is expected to reach USD 132.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.3% from 2021 to 2028. The growing prevalence of various infectious diseases caused by several micro-organisms, such as bacteria, fungi, viruses, and parasites, coupled with the rising demand for supplements to increase the body's immune system, is expected to boost the immune health supplements adoption across the globe. Besides, increasing adoption of immunity-boosting products due to the COVID-19 pandemic is also anticipated to accelerate the market growth over the forecast years. According to the Council for Responsible Nutrition (CRN) report in 2020, the consumption of dietary supplements among Americans was about 73 percent. However, taking dietary supplements among individuals for immune health has been increased from 27 percent to 32 percent from 2019 to 2020.


Key Insights & Findings:

  • The market is expected to grow well over the forecast period owing to the increasing prevalence of several infectious diseases and growing awareness to improve immune health
  • The vitamin and mineral supplements segment dominated the market in 2020 owing to high demand and increasing use for immune health
  • The respiratory tract infection application segment dominated the market in 2020 owing to the increasing adoption of immune supplements to reduce the risk of respiratory tract infection across the globe
  • The self-medication segment dominated the market in 2020 majorly due to a growing preference for self-medicated use of supplements than prescription-based
  • The pharmacies/drug stores segment dominated the market in 2020 owing to the availability of a wide range of products and high consumer preference
  • North America dominated the market in 2020 majorly due to high spending capacity and increasing uses of immune health supplements in the region

Read 150 page market research report, "Immune Health Supplements Market Size, Share & Trends Analysis Report By Product, By Form, By Application, By Mode Of Medication, By Distribution Channel, By Region, And Segment Forecasts, 2021 - 2028", by Grand View Research

As of 2020, the vitamin and mineral supplements segment held the largest revenue share. The increasing adoption of vitamin C, D, multivitamins, and minerals resulted in a high revenue share for the segment in the market. An unhealthy diet limited physical activity, and a sedentary lifestyle are the key factors responsible for increasing vitamin and mineral intake to improve an individual's immunity, especially in the developed regions such as North America and Europe. However, the increasing patient population and growing awareness for vitamin and mineral consumption are the major factors expected to boost market growth in emerging economies such as Asia Pacific and Latin America during the forecast period. However, the herbal supplements segment is also anticipated to be the second-largest product segment due to its popularity for long-term consumption as immunity boosters without any side effects.

By form, the tablets segment accounted for the largest revenue share in 2020. Due to its longer shelf life and high preference of adoption among the individual's tablets segment is expected to be the dominated segment. Tablets are more stable than the capsule, particularly in moist environments. In addition, tablets are largely manufactured by the key market players than the other form of supplements. Further, properties of tablets such as durability, inexpensive, can be split into two parts, and higher dosage accommodation is anticipated its high adoption and maximum value share in the market.

The respiratory tract infection segment held the largest revenue share in 2020. Due to the increasing prevalence of respiratory disorders such as COPD, asthma, COVID19, immune health supplements adoption has increased in the last couple of years. Particularly, the rapid rise in life-threatening coronavirus disease from the last year has increased the adoption of immunity-boosting products to manage respiratory tract infections. Taking supplements such as Vitamin C, D, and minerals such as zinc and probiotics offers unique properties to reduce the risk of respiratory tract infection, duration, and severity of infection.

As of 2020, the self-medication segment accounted for the largest revenue share than the prescription-based segment. It can be attributed due to the high percentage of self-medicated supplements using the population around the globe. Further, most of the vitamins and mineral supplements do not require a prescription. One can purchase them from pharmacies, groceries, and any convenience stores. Besides, the growing awareness among the individuals to use immunity-boosting products due to COVID19 is also expected to provide a high market share to the self-medication segment over the forecast years globally.

The pharmacies/drug stores segment dominated the market and accounted for the largest revenue in 2020. The availability of a wide variety of products and the high preference of consumers to buy immune health supplements from pharmacies are the factors responsible for the largest market share of this segment. Moreover, the availability of both prescriptions based and over-the-counter products for the consumers is also expected to accelerate the growth of the Pharmacies/drug stores segment over the forecast years.

North America dominated the market and accounted for the largest revenue share in 2020. The increasing prevalence of various health disorders, increasing usage of immune-enhancing products, and high spending capacity by the consumers are the factors anticipated to provide the majority of market share to the region. However, Asia Pacific countries, such as China, India, and Japan, are expected to witness significant growth over the forecast years due to the large population, increasing awareness, and growing consumer base in these countries.

Grand View Research, Inc. has segmented the global immune health supplements market based on product, form, application, mode of medication, distribution channel, and region:

  • Immune Health Supplements Product Outlook (Revenue, USD Million, 2016 - 2028)
    • Vitamin and Mineral Supplements
      • Vitamin C Supplements
      • Vitamin D Supplements
      • Vitamin B complex Supplements
      • Multivitamins
      • Selenium Supplements
      • Zinc Supplements
      • Others
    • Herbal Supplements
    • Probiotic Supplements
    • Others
  • Immune Health Supplements Form Outlook (Revenue, USD Million, 2016 - 2028)
    • Capsules
    • Tablets
    • Powder
    • Liquid
    • Gel
    • Softgels
    • Others
  • Immune Health Supplements Application Outlook (Revenue, USD Million, 2016 - 2028)
    • Hair growth
    • Gut health
    • Respiratory tract infection
    • Others
  • Immune Health Supplements Mode Of Medication Outlook (Revenue, USD Million, 2016 - 2028)
    • Prescription based
    • Self-medication
  • Immune Health Supplements Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)
    • Pharmacies/Drug Stores
    • Supermarkets and Hypermarkets
    • E-commerce
    • Others
  • Immune Health Supplements Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • Singapore
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • MEA
      • South Africa
      • Saudi Arabia
      • UAE

List of Key Players of Immune Health Supplements Market

  • Bayer AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
  • Swisse Wellness Pty Ltd.
  • GlaxoSmithKline
  • Abbott Laboratories
  • Amway Corp.
  • The Nature's Bounty Co.
  • Herbalife Nutrition of America, Inc.
  • Himalaya Global Holdings Ltd.
  • American Health
  • Unilever
  • Sanofi
  • Novartis
  • Boehringer Ingelheim
  • Nestl√®
  • Danone

Check out more studies related to health & Immunity supplements, conducted by Grand View Research:

  • Sodium Hyaluronate-based Products Market – The global sodium hyaluronate-based products market size was valued at USD 8.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2021 to 2028. The growth of the market can be attributed to an increase in the geriatric population, a demographic that is prone to diseases such as osteoarthritis and cataracts.
  • Complete Nutrition Products Market – The global complete nutrition products market size was valued at USD 3.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.0% from 2021 to 2028. Complete nutrition products are gaining popularity among consumers owing to the increasing focus on health, natural ingredients, clean labels, and organic food alternatives.
  • Gummy Market – The global gummy market size was valued at USD 16.28 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 12.6% from 2020 to 2028. The market is witnessing significant growth owing to the rising health-conscious consumer base demanding easy-to-consume dosage forms of supplements.

Browse through Grand View Research's coverage of the Global Pharmaceuticals Industry

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.


Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Follow Us: LinkedIn | Twitter 

Cision View original content:

SOURCE Grand View Research, Inc.

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.